Cargando…
Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy
Several tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptors and molecules inhibiting the mammalian target of rapamycin are being used for management of metastatic renal cell carcinoma (mRCC); however, there is still a potential for improvement. Immune checkpoint inh...
Autores principales: | Venur, Vyshak Alva, Joshi, Monika, Nepple, Kenneth G, Zakharia, Yousef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395273/ https://www.ncbi.nlm.nih.gov/pubmed/28442891 http://dx.doi.org/10.2147/DDDT.S110209 |
Ejemplares similares
-
Targeted Therapies for Brain Metastases from Breast Cancer
por: Venur, Vyshak Alva, et al.
Publicado: (2016) -
Targeting Molecular Pathways in Intracranial Metastatic Disease
por: Venur, Vyshak Alva, et al.
Publicado: (2019) -
Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy
por: Faulkner, Michele A
Publicado: (2017) -
Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2017) -
Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy
por: Davis, Elizabeth J, et al.
Publicado: (2017)